Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1992-9-17
|
| pubmed:abstractText |
The varying tumor-biological behavior of ovarian carcinomas probably influences both their operability and response to chemotherapy, which are the most relevant prognostic factors. The phenotype of different ovarian carcinomas is obviously associated with an activation of the EGF/TGF-alpha signal pathway, including c-myc and c-jun expression. Analysis of EGF-R, TGF-alpha, c-myc and c-jun expression in 33 stage III/IV, and 2 stage I/II ovarian carcinomas with biochemical, molecular-chemical and immunohistochemical methods showed a correlation between the mRNA and protein levels of EGF-R and TGF-alpha for tumors with low or high expressing rates. However, the concentration of measurable free EGF-Rs seems to depend on the amount of TGF-alpha expression by the tumors. The EGF-R binding ligand TGF-alpha is produced by epithelial tumor cells; stromal cells are usually TGF-alpha-negative, as shown by immunohistochemistry. High expression rates of EGF-R. TGF-alpha and c-myc were detected in 6, 7, and 10 out of 35 ovarian carcinomas, respectively. C-jun mRNA was detected in 18/19 cases studied. Non-malignant tissues originating from myometrium or ovary expressed no (or only small amounts of) EGF-R or TGF-alpha mRNA, whereas a high c-myc expression was found in 1/7 normal myometria, and in 2/5 normal ovaries. There was no strong correlation between EGF-R/TGF-alpha and c-myc/c-jun expression.(ABSTRACT TRUNCATED AT 250 WORDS)
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0300-8835
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
155
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
19-24
|
| pubmed:dateRevised |
2009-11-19
|
| pubmed:meshHeading |
pubmed-meshheading:1502888-Blotting, Northern,
pubmed-meshheading:1502888-Female,
pubmed-meshheading:1502888-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:1502888-Genes, jun,
pubmed-meshheading:1502888-Genes, myc,
pubmed-meshheading:1502888-Humans,
pubmed-meshheading:1502888-Immunohistochemistry,
pubmed-meshheading:1502888-Ovarian Neoplasms,
pubmed-meshheading:1502888-RNA, Messenger,
pubmed-meshheading:1502888-Receptor, Epidermal Growth Factor,
pubmed-meshheading:1502888-Signal Transduction,
pubmed-meshheading:1502888-Transforming Growth Factor alpha
|
| pubmed:year |
1992
|
| pubmed:articleTitle |
Oncogene and growth factor expression in ovarian cancer.
|
| pubmed:affiliation |
Department of Gynaecology, Albert-Ludwig University, Freiburg, Germany.
|
| pubmed:publicationType |
Journal Article
|